Provenienza dei contatti di primo grado di Frank Waligora
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Frank Waligora tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| IMUNON, INC. | Biotechnology | Director/Board Member | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| XOMA ROYALTY CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| XENCOR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CARA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
CytoMed, Inc.
 CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| Boston College | College/University | Undergraduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Masters Business Admin | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree Corporate Officer/Principal | |
| DNAX Research, Inc. | Corporate Officer/Principal | ||
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CUE BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Immtox LLC | Founder | ||
| Lak505, LLC | Corporate Officer/Principal | ||
| Axon Healthcare Ltd. | Corporate Officer/Principal | ||
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Pharmaceuticals: Major | Director/Board Member | |
| CereXis, Inc. | Chief Executive Officer | ||
Novasenta, Inc.
 Novasenta, Inc. Miscellaneous Commercial ServicesCommercial Services Novasenta, Inc. develops therapies for cancer. The company is based in Pittsburgh, PA. The company was founded by Greg Delgoffe, Robert L. Ferris, Dario Vignali. Mani Mohindru has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| VALERITAS INC | Medical Specialties | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Stati Uniti | 50 |
| India | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 9 |
| Process Industries | 2 |
| Finance | 2 |
| Retail Trade | 2 |
Posizioni
| Director/Board Member | 78 |
| Corporate Officer/Principal | 64 |
| Independent Dir/Board Member | 27 |
| Chief Tech/Sci/R&D Officer | 25 |
| Doctorate Degree | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Lori Kunkel | 27 |
| James Tobin | 26 |
| Susan B. Bayh | 20 |
| Robert Martell | 18 |
| Joseph M. Davie | 17 |
| Mani Mohindru | 15 |
| James McNab | 14 |
| Michael Gray | 12 |
| Ali Fattaey | 10 |
| Daniel Passeri | 9 |
| James Dentzer | 9 |
| Kenneth J. Pienta | 8 |
| Minji Kim | 8 |
| David Tuck | 7 |
| Mitchell Keegan | 6 |
- Borsa valori
- Insiders
- Frank Waligora
- Connessioni Società
